EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.1.2.6 | structure of SeMet-substituted protein, to 1.65 A resolution. Four monomers of GloB are observed in the asymmetric unit. GloB exhibits the classic alphabeta/betalpha-fold that defines the metallo-beta-lactamases | Staphylococcus aureus |
3.1.2.12 | structure to 1.6 A resolution. A single dimer of FrmB is observed in the asymmetric unit. The overall fold of FrmB is characteristic of the alpha/beta-hydrolase fold | Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.2.6 | Staphylococcus aureus | A0A0D1GCF8 | - |
- |
3.1.2.12 | Staphylococcus aureus | Q2FUY3 | - |
- |
3.1.2.12 | Staphylococcus aureus PS 47 | Q2FUY3 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.2.6 | (S)-D-lactoylglutathione + H2O | - |
Staphylococcus aureus | D-lactate + glutathione | - |
? | |
3.1.2.6 | bis(pivaloyloxymethyl)(1-hydroxy-2-oxopiperidin-3-yl)phosphonate + H2O | i.e. POM-HEX, substrate is a prodrug of the compound HEX, which inhibits the glycolytic enzyme enolase | Staphylococcus aureus | [[(hydroxymethoxy)(1-hydroxy-2-oxopiperidin-3-yl)phosphoryl]oxy]methyl 2,2-dimethylpropanoate + 2,2-dimethylpropanoate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis(2-methoxypropanoate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl 2-methoxypropanoate + 2-methoxypropanoate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis(ethoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-yoxymethyl ethoxyacetate + ethoxyacetate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis(methoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl methoxyacetate + methoxyacetate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis(propoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl propoxyacetate + propoxyacetate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis[(ethylsulfanyl)acetate] + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl (ethylsulfanyl)acetate + (ethylsulfanyl)acetate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene bis[(methylsulfanyl)acetate] + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl (methylsulfanyl)acetate + (methylsulfanyl)acetate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene dibutanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl butanoate + butanoate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene dihexanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl hexanoate + hexanoate | - |
? | |
3.1.2.6 | fluorescein-3',6'-bis(oxy)methylene dipentanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl pentanoate + pentanoate | - |
? | |
3.1.2.6 | additional information | no substrates: 4-nitrophenyl acetate, 4-nitrophenyl butanoate, 4-nitrophenyl trimethylacetate | Staphylococcus aureus | ? | - |
- |
|
3.1.2.12 | (S)-D-lactoylglutathione + H2O | - |
Staphylococcus aureus | D-lactate + glutathione | - |
? | |
3.1.2.12 | (S)-D-lactoylglutathione + H2O | - |
Staphylococcus aureus PS 47 | D-lactate + glutathione | - |
? | |
3.1.2.12 | bis(pivaloyloxymethyl)(1-hydroxy-2-oxopiperidin-3-yl)phosphonate + H2O | i.e. POM-HEX, substrate is a prodrug of the compound HEX,which inhibits the glycolytic enzyme enolase | Staphylococcus aureus | [[(hydroxymethoxy)(1-hydroxy-2-oxopiperidin-3-yl)phosphoryl]oxy]methyl 2,2-dimethylpropanoate + 2,2-dimethylpropanoic acid | - |
? | |
3.1.2.12 | bis(pivaloyloxymethyl)(1-hydroxy-2-oxopiperidin-3-yl)phosphonate + H2O | i.e. POM-HEX, substrate is a prodrug of the compound HEX,which inhibits the glycolytic enzyme enolase | Staphylococcus aureus PS 47 | [[(hydroxymethoxy)(1-hydroxy-2-oxopiperidin-3-yl)phosphoryl]oxy]methyl 2,2-dimethylpropanoate + 2,2-dimethylpropanoic acid | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(2-methoxypropanoate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl 2-methoxypropanoate + 2-methoxypropanoate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(2-methoxypropanoate) + H2O | - |
Staphylococcus aureus PS 47 | fluorescein-3'-oxymethyl 2-methoxypropanoate + 2-methoxypropanoate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(ethoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-yoxymethyl ethoxyacetate + ethoxyacetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(ethoxyacetate) + H2O | - |
Staphylococcus aureus PS 47 | fluorescein-3'-yoxymethyl ethoxyacetate + ethoxyacetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(methoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl methoxyacetate + methoxyacetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis(propoxyacetate) + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl propoxyacetate + propoxyacetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis[(methylsulfanyl)acetate] + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl (methylsulfanyl)acetate + (methylsulfanyl)acetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene bis[[(propan-2-yl)sulfanyl]acetate] + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl [(propan-2-yl)sulfanyl]acetate + [(propan-2-yl)sulfanyl]acetate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene dibutanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl butanoate + butanoate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene dihexanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl hexanoate + hexanoate | - |
? | |
3.1.2.12 | fluorescein-3',6'-bis(oxy)methylene dipentanoate + H2O | - |
Staphylococcus aureus | fluorescein-3'-oxymethyl pentanoate + pentanoate | - |
? | |
3.1.2.12 | additional information | enzyme shows modest activity with substrates 4-nitrophenyl acetate, 4-nitrophenyl butanoate, but not with 4-nitrophenyl trimethylacetate | Staphylococcus aureus | ? | - |
- |
|
3.1.2.12 | additional information | enzyme shows modest activity with substrates 4-nitrophenyl acetate, 4-nitrophenyl butanoate, but not with 4-nitrophenyl trimethylacetate | Staphylococcus aureus PS 47 | ? | - |
- |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.1.2.6 | ? | x * 23300, calculated from sequence and SDS-PAGE | Staphylococcus aureus |
3.1.2.12 | ? | x * 29500, calculated from sequence and SDS-PAGE | Staphylococcus aureus |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.2.6 | A7Q05_1268 | - |
Staphylococcus aureus |
3.1.2.6 | GloB | - |
Staphylococcus aureus |
3.1.2.12 | FrmB | - |
Staphylococcus aureus |
3.1.2.12 | SAOUHSC_02962 | - |
Staphylococcus aureus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.1.2.6 | metabolism | GloB activates the prodrug bis(pivaloyloxymethyl) (1-hydroxy-2-oxopiperidin-3-yl)phosphonate. Mutation of GloB renders Staphylococcus aureus sensitive to bis(pivaloyloxymethyl) (1-hydroxy-2-oxopiperidin-3-yl)phosphonate | Staphylococcus aureus |
3.1.2.6 | physiological function | GloB is active toward oxygen ethers. GloB has the highest activity against short-chain ethers, with some tolerance for branching at the first carbon beyond the ester carbonyl group. GloB exhibits a strong preference for oxygen at the beta-position to the carbonyl over the gamma-position but is indifferent to the positioning of sulfur | Staphylococcus aureus |
3.1.2.12 | metabolism | FrmB activates the prodrug bis(pivaloyloxymethyl) (1-hydroxy-2-oxopiperidin-3-yl)phosphonate. Mutation of FrmB renders Staphylococcus aureus sensitive to bis(pivaloyloxymethyl) (1-hydroxy-2-oxopiperidin-3-yl)phosphonate | Staphylococcus aureus |
3.1.2.12 | physiological function | FrmB has the highest activity toward oxygen ethers. FrmB hydrolyzes unbranched substrates with little regard for chain length or the end-of-chain bulk within the tested substrates. Branching at the position following the ester carbonyl is deleterious to FrmB activity. When oxygen is included in the chain, positioning at the beta-position to the carbonyl is strongly preferred over the gamma-position | Staphylococcus aureus |